Engineered biologics win FDA nod, opening doors across the blood–brain barrier

1 min read
Source: Nature
Engineered biologics win FDA nod, opening doors across the blood–brain barrier
Photo: Nature
TL;DR Summary

The first FDA-approved engineered biologic that can cross the blood–brain barrier marks a milestone in CNS drug delivery, as researchers accelerate brain-shuttle approaches to ferry large-molecule therapies into the brain for potential treatments of neurological diseases.

Share this article

Reading Insights

Total Reads

0

Unique Readers

3

Time Saved

9 min

vs 10 min read

Condensed

98%

1,91836 words

Want the full story? Read the original article

Read on Nature